Fracture prediction and calibration of a Canadian FRAX® tool: A population-based report from CaMos

Osteoporosis International

Volumn 22, Issue 3, 2011, Pages 829-837

  Fraser, L A ^a   Langsetmo, L ^b   Berger, C ^b   Ioannidis, G ^a   Goltzman, D ^b   Adachi, J D ^a   Papaioannou, A ^a   Josse, R ^c   Kovacs, C S ^d   Olszynski, W P ^e   Towheed, T ^f   Hanley, D A ^g   Kaiser, S M ^h   Prior, J ⁱ   Jamal, S ^c   Kreiger, N ^k   Brown, J P ^j   Johansson, H ^l   Oden, A ^l   McCloskey, E ^m   Kanis, J A ⁿ   Leslie, W D ⁿ   more..

^a MCMASTER UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

^f QUEEN S UNIVERSITY   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j UNIVERSITÉ LAVAL   (Canada)

^k CANCER CARE ONTARIO   (Canada)

^l Northern General Hospital ^*

^m UNIVERSITY OF SHEFFIELD   (United Kingdom)

ⁿ UNIVERSITY OF MANITOBA   (Canada)

more..

Author keywords

Canada; Fracture; Fracture prediction; FRAX; Osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; CALIBRATION; CANADA; FEMALE; FEMUR NECK; FRACTURE; FRAGILITY FRACTURE; GROUPS BY AGE; HIP FRACTURE; HUMAN; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; BONE DENSITY; CALIBRATION; CANADA; FEMALE; FEMUR NECK; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; OSTEOPOROTIC FRACTURES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; WORLD HEALTH ORGANIZATION;

EID: 79951671908     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1465-1     Document Type: Article

References (45)

1. C Berger D Goltzman L Langsetmo L Joseph N Kreiger A Tenenhouse KS Davison R Josse J Prior D Hanley CaMos Research Group 2010 Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis J Bone Miner Res 25 1948 1957 10.1002/jbmr.95 20499378
2. DA Hanley RG Josse 1996 Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 1. Introduction CMAJ 155 7 921 923 1:STN:280: DyaK28vjsVKitA%3D%3D 8837540 (Pubitemid 26341243)
3. SB Jaglal PG Sherry J Schatzker 1996 The impact and consequences of hip fracture in Ontario Can J Surg 39 2 105 111 1:STN:280:DyaK28zmsFOnsQ%3D%3D 8769920 (Pubitemid 26147036)
4. LJ Melton III 2003 Epidemiology worldwide Endocrinol Metab Clin North Am 32 1 1 13 10.1016/S0889-8529(02)00061-0 12699289 v (Pubitemid 36378631)
5. O Johnell JA Kanis 2006 An estimate of the worldwide prevalence and disability associated with osteoporotic fractures Osteoporos Int 17 12 1726 1733 1:STN:280:DC%2BD28nitVSksQ%3D%3D 10.1007/s00198-006-0172-4 16983459 (Pubitemid 44607392)
6. G Ioannidis A Papaioannou WM Hopman N khtar-Danesh T Anastassiades L Pickard CC Kennedy JC Prior WP Olszynski KS Davison D Goltzman L Thabane A Gafni EA Papadimitropoulos JP Brown RG Josse DA Hanley JD Adachi 2009 Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study CMAJ 181 5 265 271 19654194
7. JD Adachi G Ioannidis C Berger L Joseph A Papaioannou L Pickard EA Papadimitropoulos W Hopman S Poliquin JC Prior DA Hanley WP Olszynski T Anastassiades JP Brown T Murray SA Jackson A Tenenhouse 2001 The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada Osteoporos Int 12 11 903 908 1:STN:280: DC%2BD38%2FnvVWnuw%3D%3D 10.1007/s001980170017 11804016 (Pubitemid 34001002)
8. I Hallberg AM Rosenqvist L Kartous O Lofman O Wahlstrom G Toss 2004 Health-related quality of life after osteoporotic fractures Osteoporos Int 15 10 834 841 1:STN:280:DC%2BD2cvlvFGnsQ%3D%3D 10.1007/s00198-004-1622-5 15045468 (Pubitemid 39361955)
9. ST Harris NB Watts HK Genant CD McKeever T Hangartner M Keller CH Chesnut III J Brown EF Eriksen MS Hoseyni DW Axelrod PD Miller 1999 Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group JAMA 282 14 1344 1352 1:CAS:528:DyaK1MXmvFansr0%3D 10.1001/jama.282.14.1344 10527181 (Pubitemid 29483192)
10. A Cranney G Guyatt L Griffith G Wells P Tugwell C Rosen 2002 Meta-analyses of therapies for postmenopausal osteoporosis. IX: summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23 4 570 578 1:CAS:528:DC%2BD38Xnt1Whs78%3D 10.1210/er.2001-9002 12202472 (Pubitemid 34925651)
11. R Goeree G Blackhouse J Adachi 2006 Cost-effectiveness of alternative treatments for women with osteoporosis in Canada Curr Med Res Opin 22 7 1425 1436 10.1185/030079906X115568 16834841 (Pubitemid 44085594)
12. D Marshall O Johnell H Wedel 1996 Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures BMJ 312 7041 1254 1259 1:STN:280:DyaK283isFejtw%3D%3D 8634613 (Pubitemid 26147662)
13. A Cranney SA Jamal JF Tsang RG Josse WD Leslie 2007 Low bone mineral density and fracture burden in postmenopausal women CMAJ 177 6 575 580 17846439 (Pubitemid 47437054)
14. L Langsetmo D Goltzman CS Kovacs JD Adachi DA Hanley N Kreiger R Josse A Papaioannou WP Olszynski SA Jamal 2009 Repeat low-trauma fractures occur frequently among men and women who have osteopenic bone mineral density J Bone Miner Res 24 9 1515 1522 10.1359/jbmr.090319 19338456
15. JA Kanis O Johnell A Oden H Johansson E McCloskey 2008 FRAX and the assessment of fracture probability in men and women from the UK Osteoporos Int 19 4 385 397 1:STN:280:DC%2BD1c7nvF2ntA%3D%3D 10.1007/s00198-007-0543-5 18292978
16. JA Kanis A Oden O Johnell H Johansson C De Laet J Brown P Burckhardt C Cooper C Christiansen S Cummings JA Eisman S Fujiwara C Gluer D Goltzman D Hans MA Krieg CA La E McCloskey D Mellstrom LJ Melton III H Pols J Reeve K Sanders AM Schott A Silman D Torgerson W van ST YN NB 2007 The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women Osteoporos Int 18 8 1033 1046 1:STN:280:DC%2BD2sznvV2hug%3D%3D 10.1007/s00198-007-0343-y 17323110 (Pubitemid 47020000)
17. WD Leslie S O'Donnell C Lagace P Walsh C Bancej S Jean K Siminoski S Kaiser DL Kendler S Jaglal 2009 Population-based Canadian hip fracture rates with international comparisons Osteoporos Int 21 1317 1322 10.1007/s00198-009- 1080-1 19802507
18. B Ettinger DM Black B wson-Hughes AR Pressman LJ Melton III 2010 Updated fracture incidence rates for the US version of FRAX Osteoporos Int 21 1 25 33 1:STN:280:DC%2BD1MjptlaqsA%3D%3D 10.1007/s00198-009-1032-9 19705048
19. N Kreiger A Tenenhouse L Joseph T MacKenzie S Poliquin JP Brown JC Prior Rittmaster 1999 Research notes: the Canadian Multicentre Osteoporosis Study (CaMos)-background, rationale, methods Can J Aging 18 376 387 10.1017/S0714980800009934
20. Y Lu T Fuerst S Hui HK Genant 2001 Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle Osteoporos Int 12 6 438 444 1:STN:280:DC%2BD3Mzpt1ensg%3D%3D 10.1007/s001980170087 11446558 (Pubitemid 32607085)
21. HK Genant 1995 Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results J Bone Miner Res 10 6 997 998 1:STN:280:DyaK28%2Fht1amtQ%3D%3D 10.1002/jbmr.5650100623 7572326
22. C Berger L Langsetmo L Joseph D Hanley KS Davison RG Josse N Kreiger A Tenenhouse D Goltzman 2008 Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents Can Med Assoc J 178 13 1660 1668 10.1503/cmaj.071416 (Pubitemid 351897981)
23. Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2010) Independent clinical validation of a Canadian FRAX® tool: fracture prediction and model calibration. J Bone Miner Res. doi: 10.1002/jbmr.123
24. JA Kanis O Johnell C De Laet B Jonsson A Oden AK Ogelsby 2002 International variations in hip fracture probabilities: implications for risk assessment J Bone Miner Res 17 7 1237 1244 10.1359/jbmr.2002.17.7.1237 12096837 (Pubitemid 34680500)
25. JA Kanis A Oden H Johansson F Borgstrom O Strom E McCloskey 2009 FRAX and its applications to clinical practice Bone 44 5 734 743 10.1016/j.bone.2009.01. 373 19195497
26. S Fujiwara T Nakamura H Orimo T Hosoi I Gorai A Oden H Johansson JA Kanis 2008 Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX) Osteoporos Int 19 4 429 435 1:STN:280: DC%2BD1c7nvF2ntw%3D%3D 10.1007/s00198-007-0544-4 18292977
27. B Dawson-Hughes AN Tosteson LJ Melton III S Baim MJ Favus S Khosla RL Lindsay 2008 Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA Osteoporos Int 19 4 449 458 1:STN:280: DC%2BD1c7nvF2nsQ%3D%3D 10.1007/s00198-008-0559-5 18292975
28. K Lippuner H Johansson JA Kanis R Rizzoli 2010 FRAX assessment of osteoporotic fracture probability in Switzerland Osteoporos Int 21 3 381 389 10.1007/s00198-009-0975-1 19517155
29. K Siminoski WD Leslie H Frame A Hodsman RG Josse A Khan BC Lentle J Levesque DJ Lyons G Tarulli JP Brown 2005 Recommendations for bone mineral density reporting in Canada Can Assoc Radiol J 56 3 178 188 16144280 (Pubitemid 41133860)
30. JB Richards WD Leslie L Joseph K Siminoski DA Hanley JD Adachi JP Brown S Morin A Papaioannou RG Josse JC Prior KS Davison A Tenenhouse D Goltzman 2007 Changes to osteoporosis prevalence according to method of risk assessment J Bone Miner Res 22 2 228 234 10.1359/jbmr.061109 17129177 (Pubitemid 46167793)
31. WD Leslie JF Tsang LM Lix 2009 Simplified system for absolute fracture risk assessment: clinical validation in Canadian women J Bone Miner Res 24 2 353 360 10.1359/jbmr.081012 19514851
32. P Chen JH Krege JD Adachi JC Prior A Tenenhouse JP Brown E Papadimitropoulos N Kreiger WP Olszynski RG Josse D Goltzman 2009 Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk J Bone Miner Res 24 3 495 502 10.1359/jbmr.081103 19016585
33. H Johansson JA Kanis A Oden O Johnell E McCloskey 2009 BMD, clinical risk factors and their combination for hip fracture prevention Osteoporos Int 20 10 1675 1682 1:STN:280:DC%2BD1MngtFaquw%3D%3D 10.1007/s00198-009-0845-x 19291344
34. O Johnell JA Kanis A Oden H Johansson C De Laet P Delmas JA Eisman S Fujiwara H Kroger D Mellstrom PJ Meunier LJ Melton III T O'Neill H Pols J Reeve A Silman A Tenenhouse 2005 Predictive value of BMD for hip and other fractures J Bone Miner Res 20 7 1185 1194 10.1359/JBMR.050304 15940371 (Pubitemid 40863806)
35. WD Leslie C Metge L Ward 2003 Contribution of clinical risk factors to bone density-based absolute fracture risk assessment in postmenopausal women Osteoporos Int 14 4 334 338 1:STN:280:DC%2BD3s3pt1Cquw%3D%3D 10.1007/s00198-003-1375-6 12730741 (Pubitemid 40824250)
36. SC Schuit M van der Klift AE Weel CE de Laet H Burger E Seeman A Hofman AG Uitterlinden JP van Leeuwen HA Pols 2004 Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study Bone 34 1 195 202 1:STN:280:DC%2BD2c%2FltVCjsg%3D%3D 10.1016/j.bone.2003.10.001 14751578 (Pubitemid 38142449)
37. ES Siris YT Chen TA Abbott E Barrett-Connor PD Miller LE Wehren ML Berger 2004 Bone mineral density thresholds for pharmacological intervention to prevent fractures Arch Intern Med 164 10 1108 1112 10.1001/archinte.164.10.1108 15159268 (Pubitemid 38668990)
38. KL Stone DG Seeley LY Lui JA Cauley K Ensrud WS Browner MC Nevitt SR Cummings 2003 BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures J Bone Miner Res 18 11 1947 1954 10.1359/jbmr.2003.18.11.1947 14606506 (Pubitemid 37377443)
39. C De Laet JA Kanis A Oden H Johanson O Johnell P Delmas JA Eisman H Kroger S Fujiwara P Garnero EV McCloskey D Mellstrom LJ Melton III PJ Meunier HA Pols J Reeve A Silman A Tenenhouse 2005 Body mass index as a predictor of fracture risk: a meta-analysis Osteoporos Int 16 11 1330 1338 10.1007/s00198-005-1863-y 15928804 (Pubitemid 41532085)
40. JA Kanis H Johansson A Oden O Johnell C De Laet JA Eisman EV McCloskey D Mellstrom LJ Melton III HA Pols J Reeve AJ Silman A Tenenhouse 2004 A family history of fracture and fracture risk: a meta-analysis Bone 35 5 1029 1037 1:STN:280:DC%2BD2crmvV2kug%3D%3D 10.1016/j.bone.2004.06.017 15542027 (Pubitemid 39487348)
41. JA Kanis O Johnell C De Laet H Johansson A Oden P Delmas J Eisman S Fujiwara P Garnero H Kroger EV McCloskey D Mellstrom LJ Melton H Pols J Reeve A Silman A Tenenhouse 2004 A meta-analysis of previous fracture and subsequent fracture risk Bone 35 2 375 382 1:STN:280:DC%2BD2czmsVCntg%3D%3D 10.1016/j.bone.2004.03.024 15268886 (Pubitemid 38953182)
42. JA Kanis H Johansson A Oden O Johnell M de LC III LJ A Tenenhouse J Reeve AJ Silman HA Pols JA Eisman EV McCloskey D Mellstrom 2004 A meta-analysis of prior corticosteroid use and fracture risk J Bone Miner Res 19 6 893 899 10.1359/JBMR.040134 15125788 (Pubitemid 41103445)
43. JA Kanis H Johansson O Johnell A Oden C De Laet JA Eisman H Pols A Tenenhouse 2005 Alcohol intake as a risk factor for fracture Osteoporos Int 16 7 737 742 10.1007/s00198-004-1734-y 15455194 (Pubitemid 40933589)
44. JA Kanis O Johnell A Oden H Johansson C De Laet JA Eisman S Fujiwara H Kroger EV McCloskey D Mellstrom LJ Melton H Pols J Reeve A Silman A Tenenhouse 2005 Smoking and fracture risk: a meta-analysis Osteoporos Int 16 2 155 162 1:STN:280:DC%2BD2M%2FksVentA%3D%3D 10.1007/s00198-004-1640-3 15175845 (Pubitemid 40193202)
45. F Borgstrom O Johnell JA Kanis B Jonsson C Rehnberg 2006 At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis Osteoporos Int 17 10 1459 1471 1:STN:280:DC%2BD28rksVeisA%3D%3D 10.1007/s00198-006-0107-0 16847588 (Pubitemid 44387481)